Researchers led by Petrov et al. in Nature Communications developed a dual-display ESAC library that provides three levels of conformational restraint in cyclic peptides: open, semi-closed, and fully closed. This 56 million-member library addresses purity and diversity issues in conventional…
# DNA-Encoded Libraries Enable Tunable Cyclic Peptide Discovery
A study by Petrov et al. in Nature Communications presents a dual-display ESAC library with a two-step cyclization method. This approach achieves three levels of conformational restraint, open, semi-closed, and fully closed, in a single library of 56 million members. Such control allows screening vast chemical spaces for high-affinity cyclic peptide ligands suited to specific protein targets.
DNA-encoded chemical library technology builds large compound sets at low cost, but standard methods falter for cyclic peptides. They suffer from low purity due to sequential split-and-pool steps on one DNA strand, where uneven reactions reduce final quality. Cyclization typically occurs in one step, yielding either too flexible linear forms or rigid cycles, missing intermediate conformations preferred by many targets.
Unlike typical DNA-encoded libraries, this method included HPLC purification and mass spectrometry after the first amino acid coupling for each sub-library. Purified sub-libraries then mixed for encoding and cyclization, preventing cumulative purity loss. Fully closed members showed molecular weights centered at 2000-4000 Da, aligning with common cyclic peptide drugs.
Streptavidin selections also favored semi-closed peptides, with clicked formats showing strong affinity over open ones. Off-DNA tests with C-terminal linkers preserved binding only in the open C-terminus form, while cyclized versions lost activity. These peptides selected streptavidin over avidin and neutravidin, suggesting uses in reagent development.
Selections against PLAP enriched open conformation peptides unexpectedly. Analysis pointed to incomplete diazotransfer in synthesis, favoring free amine over azide forms. Resynthesized amine compounds outperformed azides and stayed open, showing PLAP prefers linear or partially constrained peptides over fully cyclized ones.
This work proves the benefits of precise conformational control in screening. Targets displayed unique flexibility preferences, aiding rational cyclic peptide design. For projects, access to our Free peptide tools /tools such as the Reconstitution Calculator /tools/peptide-reconstitution-calculator and Dosage & Cycle Planner /tools/peptide-dosage-planner supports handling research compounds like those in BPC-157 Research Guide /product/bpc-157 .
Fine-tuned libraries overcome purity and diversity limits in cyclic peptide discovery. Validated hits from such screens require resynthesis, structure-activity relationship studies, and property optimization for solubility, stability, and permeability. These steps demand expertise in synthesis and characterization to advance leads.
---
Looking for high-purity research peptides? Browse our catalog for HPLC-verified compounds.
| Compound | Purity | Size | Price |
|---|---|---|---|
| BPC-157 5mg /product/bpc-157-5mg | ≥98% | 5mg | $34.00 |
| BPC-157 10mg /product/bpc-157-10mg | ≥98% | 10mg | $44.00 |
Browse Full Catalog → /catalog
Peptides referenced: BPC-157.
Related reading: Oligonucleotide Drug Product Development and Manufacturing, Boost Focus and Clarity with Selank and Semax Duo, Insulin-Like Growth Factors: IGF-1 and IGF-2 Explained, Retatrutide Monthly Research Cost in Australia Breakdown.